Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Dec 31, 2025
Reporting period
Not applicable
Filed with the SEC
Jan 5, 2026
DirectorGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references dividend reinvestment
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001587868-26-000002
Filed / recorded
Jan 5, 2026, 9:07 PM UTC
Added to OQRO
Oct 2, 2026, 12:29 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
ZIMMER BIOMET HOLDINGS, INC.
Issuer CIK
1136869
Ticker
ZBH
Reporting person
Maria Teresa Hilado
Relationship
Director
Security
Phantom Stock Units
Table
Derivative (Table II)
Transaction date
Dec 31, 2025
Transaction code
A
Shares / units
373.63
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
11,275.465
Ownership form
Direct
Amendment
No
Footnotes from the filing
The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
The Conversion or Exercise Price of Derivative Security is 1-for-1.
Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.
Includes 26.117 phantom stock units accrued on October 31, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.